Furosemide Market By Product and Application - Global Industry Analysis And Forecast To 2025

CRY2876801
180 Pages
January 2019
Pharmaceuticals

Download Sample Get Discount

Furosemide Market By Product (Solution, Injection and Tablet) and Application (Clinics, Hospital and Pharmacy) - Global Industry Analysis And Forecast To 2025

Industry Outlook

Furosemide is a strong diuretic (water pill) that is utilized to take out water and salt from the body. In the kidneys, salt, water, and other little atoms regularly are sifted through of the blood and into the tubules of the kidney. The filtered fluid ultimately eventually turns into urine. The majority of the sodium, chloride and water that is sifted through of the blood is reabsorbed into the blood before the separated liquid progresses toward becoming pee and is disposed of from the body. Furosemide works by hindering the retention of sodium, chloride, and water from the filtered liquid in the kidney tubules, causing a significant increment in the output of urine. The beginning of activity after oral organization is inside 60 minutes, and the diuresis keeps going around 6-8 hours. The market has encountered significant development over the recent years and is anticipated to grow tremendously in the upcoming years.

Market Segmentation

The Furosemide Market is based on different segments namely, by product the market is segmented into solution, injection and tablet; by application the market is segmented into clinics, hospital and pharmacy.

Furosemide Market By Product

Solution

Injection

Tablet

Furosemide Market By Product

Clinics

Hospital

Pharmacy

Regional Insights

On a global front, the Furosemide Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North America is anticipated to grow significantly over the forecast period trailed by Europe owing to various developing healthcare infrastructure.

Furosemide Market, By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Russia

Italy

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Rest of Asia-Pacific

South America

Brazil

Argentina

Columbia

Rest of South America

Middle East and Africa

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Rest of MEA

Competitive Analysis

The leading players in the market are Hospira, Ivax Sub Teva Pharms, Sanofi, Sandoz, Furosemide, Emcure Pharmaceuticals Ltd, US Pharm Holdings, West-Ward Pharmaceuticals, Mylan, Sun Pharmaceutical Industries Ltd. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

Hospira

Ivax Sub Teva Pharms

Sanofi

Sandoz

Furosemide

Emcure Pharmaceuticals Ltd

US Pharm Holdings

West-Ward Pharmaceuticals

Mylan

Sun Pharmaceutical Industries Ltd

Some of the key questions answered by the report are:

What was the market size in 2014 and forecast from 2015 to 2025?

What will be the industry market growth from 2015 to 2025?

What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?

What are the major segments leading the market growth and why?

Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Table of Contents:

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market Status and Outlook (2014-2025)

4.1.2. Canada Market Status and Outlook (2014-2025)

4.1.3. Mexico Market Status and Outlook (2014-2025)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market Status and Outlook (2014-2025)

4.2.2. France Market Status and Outlook (2014-2025)

4.2.3. UK Market Status and Outlook (2014-2025)

4.2.4. Russia Market Status and Outlook (2014-2025)

4.2.5. Italy Market Status and Outlook (2014-2025)

4.2.6. Rest of Europe Market Status and Outlook (2014-2025)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market Status and Outlook (2014-2025)

4.3.2. Japan Market Status and Outlook (2014-2025)

4.3.3. Korea Market Status and Outlook (2014-2025)

4.3.4. India Market Status and Outlook (2014-2025)

4.3.5. Southeast Asia Market Status and Outlook (2014-2025)

4.3.6. Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market Status and Outlook (2014-2025)

4.4.2. Argentina Market Status and Outlook (2014-2025)

4.4.3. Columbia Market Status and Outlook (2014-2025)

4.4.4. Rest of South America Market Status and Outlook (2014-2025)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2. United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3. Egypt Market Status and Outlook (2014-2025)

4.5.4. Nigeria Market Status and Outlook (2014-2025)

4.5.5. South Africa Market Status and Outlook (2014-2025)

4.5.6. Turkey Market Status and Outlook (2014-2025)

4.5.7. Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5. Furosemide Market, By Product

5.1. Introduction

5.2. Global Furosemide Revenue and Market Share by Product (2014-2018)

5.2.1. Global Furosemide Revenue and Revenue Share by Product (2014-2018)

5.3. Solution

5.3.1. Global Solution Revenue and Growth Rate (2014-2018)

5.4. Injection

5.4.1. Global Injection Revenue and Growth Rate (2014-2018)

5.5. Tablet

5.5.1. Global Tablet Revenue and Growth Rate (2014-2018)

6. Furosemide Market, By Application

6.1. Introduction

6.2. Global Furosemide Revenue and Market Share by Application (2014-2018)

6.2.1. Global Furosemide Revenue and Revenue Share by Application (2014-2018)

6.3. Clinics

6.3.1. Global Clinics Revenue and Growth Rate (2014-2018)

6.4. Hospital

6.4.1. Global Hospital Revenue and Growth Rate (2014-2018)

6.5. Pharmacy

6.5.1. Global Pharmacy Revenue and Growth Rate (2014-2018)

7. Furosemide Market, By Region

7.1. Introduction

7.2. Global Furosemide Revenue and Market Share by Regions

7.2.1. Global Furosemide Revenue by Regions (2014-2018)

7.3. North America Furosemide by Countries

7.3.1. North America Furosemide Revenue and Growth Rate (2014-2018)

7.3.2. North America Furosemide Revenue (Million USD) by Countries (2014-2018)

7.3.3. United States

7.3.3.1. United States Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.4. Canada

7.3.4.1. Canada Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.5. Mexico

7.3.5.1. Mexico Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.4. Europe Furosemide by Countries

7.4.1. Europe Furosemide Revenue and Growth Rate (2014-2018)

7.4.2. Europe Furosemide Revenue (Million USD) by Countries (2014-2018)

7.4.3. Germany

7.4.3.1. Germany Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.4. France

7.4.4.1. France Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.5. UK

7.4.5.1. UK Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6. Russia

7.4.6.1. Russia Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7. Italy

7.4.7.1. Italy Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8. Rest of Europe

7.4.8.1. Rest of Europe Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.5. Asia-Pacific Furosemide by Countries

7.5.1. Asia-Pacific Furosemide Revenue and Growth Rate (2014-2018)

7.5.2. Asia-Pacific Furosemide Revenue (Million USD) by Countries (2014-2018)

7.5.3. China

7.5.3.1. China Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.4. Japan

7.5.4.1. Japan Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5. Korea

7.5.5.1. Korea Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6. India

7.5.6.1. India Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.7. Southeast Asia

7.5.7.1. Southeast Asia Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8. Rest of Asia-Pacific

7.5.8.1. Rest of Asia-Pacific Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.6. South America Furosemide by Countries

7.6.1. South America Furosemide Revenue and Growth Rate (2014-2018)

7.6.2. South America Furosemide Revenue (Million USD) by Countries (2014-2018)

7.6.3. Brazil

7.6.3.1. Brazil Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.4. Argentina

7.6.4.1. Argentina Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.5. Columbia

7.6.5.1. Columbia Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6. Rest of South America

7.6.6.1. Rest of South America Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.7. Middle East and Africa Furosemide by Countries

7.7.1. Middle East and Africa Furosemide Revenue and Growth Rate (2014-2018)

7.7.2. Middle East and Africa Furosemide Revenue (Million USD) by Countries (2014-2018)

7.7.3. Saudi Arabia

7.7.3.1. Saudi Arabia Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.4. United Arab Emirates

7.7.4.1. United Arab Emirates Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.5. Egypt

7.7.5.1. Egypt Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6. Nigeria

7.7.6.1. Nigeria Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7. South Africa

7.7.7.1. South Africa Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8. Turkey

7.7.8.1. Turkey Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9. Rest of Middle East and Africa

7.7.9.1. Rest of Middle East and Africa Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

8. Company Profiles

8.1. Hospira

8.1.1. Business Overview

8.1.2. Service Portfolio

8.1.3. Strategic Developments

8.1.4. Revenue and Market Share

8.2. Ivax Sub Teva Pharms

8.2.1. Business Overview

8.2.2. Service Portfolio

8.2.3. Strategic Developments

8.2.4. Revenue and Market Share

8.3. Sanofi

8.3.1. Business Overview

8.3.2. Service Portfolio

8.3.3. Strategic Developments

8.3.4. Revenue and Market Share

8.4. Sandoz

8.4.1. Business Overview

8.4.2. Service Portfolio

8.4.3. Strategic Developments

8.4.4. Revenue and Market Share

8.5. Furosemide

8.5.1. Business Overview

8.5.2. Service Portfolio

8.5.3. Strategic Developments

8.5.4. Revenue and Market Share

8.6. Emcure Pharmaceuticals Ltd

8.6.1. Business Overview

8.6.2. Service Portfolio

8.6.3. Strategic Developments

8.6.4. Revenue and Market Share

8.7. US Pharm Holdings

8.7.1. Business Overview

8.7.2. Service Portfolio

8.7.3. Strategic Developments

8.7.4. Revenue and Market Share

8.8. West-Ward Pharmaceuticals

8.8.1. Business Overview

8.8.2. Service Portfolio

8.8.3. Strategic Developments

8.8.4. Revenue and Market Share

8.9. Mylan

8.9.1. Business Overview

8.9.2. Service Portfolio

8.9.3. Strategic Developments

8.9.4. Revenue and Market Share

8.10. Sun Pharmaceutical Industries Ltd

8.10.1. Business Overview

8.10.2. Service Portfolio

8.10.3. Strategic Developments

8.10.4. Revenue and Market Share

9. Global Furosemide Market Competition, by Manufacturer

9.1. Global Furosemide Revenue and Market Share by Manufacturer (2016-2017)

9.2. Global Furosemide Price By Region (2016-2017)

9.3. Top 5 Furosemide Manufacturer Market Share

9.4. Market Competition Trend

10. Furosemide Market Forecast (2018-2025)

10.1. Global Furosemide Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Furosemide Market Forecast by Regions (2018-2025)

10.2.1. North America Furosemide Market Forecast (2018-2025)

10.2.1.1. United States Furosemide Market Forecast (2018-2025)

10.2.1.2. Canada Furosemide Market Forecast (2018-2025)

10.2.1.3. Mexico Furosemide Market Forecast (2018-2025)

10.2.2. Europe Furosemide Market Forecast (2018-2025)

10.2.2.1. Germany Furosemide Market Forecast (2018-2025)

10.2.2.2. France Furosemide Market Forecast (2018-2025)

10.2.2.3. UK Furosemide Market Forecast (2018-2025)

10.2.2.4. Russia Furosemide Market Forecast (2018-2025)

10.2.2.5. Italy Furosemide Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Furosemide Market Forecast (2018-2025)

10.2.3. Asia-Pacific Furosemide Market Forecast (2018-2025)

10.2.3.1. China Furosemide Market Forecast (2018-2025)

10.2.3.2. Japan Furosemide Market Forecast (2018-2025)

10.2.3.3. Korea Furosemide Market Forecast (2018-2025)

10.2.3.4. India Furosemide Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Furosemide Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Furosemide Market Forecast (2018-2025)

10.2.4. South America Furosemide Market Forecast (2018-2025)

10.2.4.1. Brazil Furosemide Market Forecast (2018-2025)

10.2.4.2. Argentina Furosemide Market Forecast (2018-2025)

10.2.4.3. Columbia Furosemide Market Forecast (2018-2025)

10.2.4.4. Rest of South America Furosemide Market Forecast (2018-2025)

10.2.5. Middle East and Africa Furosemide Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Furosemide Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Furosemide Market Forecast (2018-2025)

10.2.5.3. Egypt Furosemide Market Forecast (2018-2025)

10.2.5.4. Nigeria Furosemide Market Forecast (2018-2025)

10.2.5.5. South Africa Furosemide Market Forecast (2018-2025)

10.2.5.6. Turkey Furosemide Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Furosemide Market Forecast (2018-2025)

10.3. Furosemide Market Forecast by Product (2018-2025)

10.3.1. Furosemide Forecast by Product (2018-2025)

10.3.2. Furosemide Market Share Forecast by Product (2018-2025)

10.4. Furosemide Market Forecast by Application (2018-2025)

10.4.1. Furosemide Forecast by Application (2018-2025)

10.4.2. Furosemide Market Share Forecast by Application (2018-2025)

List of Tables and Figures:

Figure United States Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Canada Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Mexico Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Germany Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure France Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure UK Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Russia Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Italy Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Europe Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure China Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Japan Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Korea Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure India Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Southeast Asia Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Asia-Pacific Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Brazil Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Argentina Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Columbia Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of South America Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Saudi Arabia Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure United Arab Emirates Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Egypt Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Nigeria Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure South Africa Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Turkey Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Middle East and Africa Furosemide Revenue (Million USD) and Growth Rate (2014-2025)

Table Global Furosemide Revenue and Revenue Share by Product (2014-2018)

Figure Global Solution Revenue and Growth Rate (2014-2018)

Figure Global Injection Revenue and Growth Rate (2014-2018)

Figure Global Tablet Revenue and Growth Rate (2014-2018)

Table Global Furosemide Revenue and Revenue Share by Application (2014-2018)

Figure Global Clinics Revenue and Growth Rate (2014-2018)

Figure Global Hospital Revenue and Growth Rate (2014-2018)

Figure Global Pharmacy Revenue and Growth Rate (2014-2018)

Table Global Furosemide Revenue by Regions (2014-2018)

Figure North America Furosemide Growth Rate (2014-2018)

Figure North America Furosemide Revenue and Growth Rate (2014-2018)

Figure North America Furosemide by Countries (2014-2018)

Figure North America Furosemide Revenue (Million USD) by Countries (2014-2018)

Figure United States Furosemide Growth Rate (2014-2018)

Figure United States Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Canada Furosemide Growth Rate (2014-2018)

Figure Canada Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Mexico Furosemide Growth Rate (2014-2018)

Figure Mexico Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Europe Furosemide Growth Rate (2014-2018)

Figure Europe Furosemide Revenue and Growth Rate (2014-2018)

Figure Europe Furosemide by Countries (2014-2018)

Figure Europe Furosemide Revenue (Million USD) by Countries (2014-2018)

Figure Germany Furosemide Growth Rate (2014-2018)

Figure Germany Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure France Furosemide Growth Rate (2014-2018)

Figure France Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure UK Furosemide Growth Rate (2014-2018)

Figure UK Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Russia Furosemide Growth Rate (2014-2018)

Figure Russia Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Italy Furosemide Growth Rate (2014-2018)

Figure Italy Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Europe Furosemide Growth Rate (2014-2018)

Figure Rest of Europe Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Asia-Pacific Furosemide Growth Rate (2014-2018)

Figure Asia-Pacific Furosemide Revenue and Growth Rate (2014-2018)

Figure Asia-Pacific Furosemide by Countries (2014-2018)

Figure Asia-Pacific Furosemide Revenue (Million USD) by Countries (2014-2018)

Figure China Furosemide Growth Rate (2014-2018)

Figure China Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Japan Furosemide Growth Rate (2014-2018)

Figure Japan Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Korea Furosemide Growth Rate (2014-2018)

Figure Korea Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure India Furosemide Growth Rate (2014-2018)

Figure India Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Southeast Asia Furosemide Growth Rate (2014-2018)

Figure Southeast Asia Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Asia-Pacific Furosemide Growth Rate (2014-2018)

Figure Rest of Asia-Pacific Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure South America Furosemide Growth Rate (2014-2018)

Figure South America Furosemide Revenue and Growth Rate (2014-2018)

Figure South America Furosemide by Countries (2014-2018)

Figure South America Furosemide Revenue (Million USD) by Countries (2014-2018)

Figure Brazil Furosemide Growth Rate (2014-2018)

Figure Brazil Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Argentina Furosemide Growth Rate (2014-2018)

Figure Argentina Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Columbia Furosemide Growth Rate (2014-2018)

Figure Columbia Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of South America Furosemide Growth Rate (2014-2018)

Figure Rest of South America Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Middle East and Africa Furosemide Growth Rate (2014-2018)

Figure Middle East and Africa Furosemide Revenue and Growth Rate (2014-2018)

Figure Middle East and Africa Furosemide by Countries (2014-2018)

Figure Middle East and Africa Furosemide Revenue (Million USD) by Countries (2014-2018)

Figure Saudi Arabia Furosemide Growth Rate (2014-2018)

Figure Saudi Arabia Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure United Arab Emirates Furosemide Growth Rate (2014-2018)

Figure United Arab Emirates Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Egypt Furosemide Growth Rate (2014-2018)

Figure Egypt Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Nigeria Furosemide Growth Rate (2014-2018)

Figure Nigeria Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure South Africa Furosemide Growth Rate (2014-2018)

Figure South Africa Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Turkey Furosemide Growth Rate (2014-2018)

Figure Turkey Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Middle East and Africa Furosemide Growth Rate (2014-2018)

Figure Rest of Middle East and Africa Furosemide Revenue (Millions USD) and Growth Rate (2014-2018)

Table Hospira Furosemide Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ivax Sub Teva Pharms Furosemide Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Furosemide Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sandoz Furosemide Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Furosemide Furosemide Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Emcure Pharmaceuticals Ltd Furosemide Price, Revenue, Gross Margin and Market Share (2016-2017)

Table US Pharm Holdings Furosemide Price, Revenue, Gross Margin and Market Share (2016-2017)

Table West-Ward Pharmaceuticals Furosemide Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Furosemide Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sun Pharmaceutical Industries Ltd Furosemide Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Furosemide Market Share by Manufacturer

Figure Global Furosemide Revenue and Market Share by Manufacturer

Table Global Furosemide Price by Region (2016-2017)

Figure Top 5 Furosemide Manufacturer (Revenue) Market Share

Figure Market Competition Trend

Figure Global Furosemide Revenue (Millions USD) and Growth Rate (2018-2025)

Table Furosemide Market Forecast by Regions (2018-2025)

Figure North America Furosemide Market Forecast (2018-2025)

Figure United States Furosemide Market Forecast (2018-2025)

Figure Canada Furosemide Market Forecast (2018-2025)

Figure Mexico Furosemide Market Forecast (2018-2025)

Figure Europe Furosemide Market Forecast (2018-2025)

Figure Germany Furosemide Market Forecast (2018-2025)

Figure France Furosemide Market Forecast (2018-2025)

Figure UK Furosemide Market Forecast (2018-2025)

Figure Russia Furosemide Market Forecast (2018-2025)

Figure Italy Furosemide Market Forecast (2018-2025)

Figure Rest of Europe Furosemide Market Forecast (2018-2025)

Figure Asia-Pacific Furosemide Market Forecast (2018-2025)

Figure China Furosemide Market Forecast (2018-2025)

Figure Japan Furosemide Market Forecast (2018-2025)

Figure Korea Furosemide Market Forecast (2018-2025)

Figure India Furosemide Market Forecast (2018-2025)

Figure Southeast Asia Furosemide Market Forecast (2018-2025)

Figure Rest of Asia-Pacific Furosemide Market Forecast (2018-2025)

Figure South America Furosemide Market Forecast (2018-2025)

Figure Brazil Furosemide Market Forecast (2018-2025)

Figure Argentina Furosemide Market Forecast (2018-2025)

Figure Columbia Furosemide Market Forecast (2018-2025)

Figure Rest of South America Furosemide Market Forecast (2018-2025)

Figure Middle East and Africa Furosemide Market Forecast (2018-2025)

Figure Saudi Arabia Furosemide Market Forecast (2018-2025)

Figure United Arab Emirates Furosemide Market Forecast (2018-2025)

Figure Egypt Furosemide Market Forecast (2018-2025)

Figure Nigeria Furosemide Market Forecast (2018-2025)

Figure South Africa Furosemide Market Forecast (2018-2025)

Figure Turkey Furosemide Market Forecast (2018-2025)

Figure Rest of Middle East and Africa Furosemide Market Forecast (2018-2025)

Figure Global Furosemide Forecast by Product (2018-2025)

Figure Global Furosemide Market Share Forecast by Product (2018-2025)

Figure Global Furosemide Forecast by Product (2018-2025)

Figure Global Furosemide Forecast by Application (2018-2025)

Figure Global Furosemide Market Share Forecast by Application (2018-2025)

Figure Global Furosemide Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Purchase Options

Single User License $3800 Multiple $5800 Enterprise User License $7800

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

Publish Date: November 14, 2017
$5370

View Details

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

Publish Date: July 20, 2017
$5370

View Details

Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

Publish Date: April 24, 2017
$5370

View Details

Client Testimonials

Your team has worked hard to help and to provide our research needs to fulfill our significant initiatives...

Maria

-Researcher

The report on EAA resins was detailed and informative. However, we were hopeful to discover a Chinese producer ...

David

-President Protech Oxyplast Group

Thanks the attached report is perfect and accurate, but I was wondering if you can show the price trend in one year...

Furosemide Market By Product and Application - Global Industry Analysis And Forecast To 2025

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara